Skip to content

Research Alliance Corp III

RACC· NasdaqCore metricsCIK 2118032

Pharmaceutical preparations551 peers

Close
Oct 29, 2026 · +0.00%
Market cap
$91.90M
9.1M shares
Filings
51
—
—
—
-$1.95M
Q3 2026
—
-$977.79K
Q3 2026
—
—
—
—
-$0.06
Q1 2026
—
$183.41K
Q3 2026
—
$91.90M
—
—
—
—
—

FY2026 figures · derived

Price

$10.102.04%$0.21since May 20, 2026
Oct 29, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

General And Administrative

$977.79KQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Research Alliance Corp III is the 294th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Research Alliance Corp III · CIK 2118032 · Engraved from SEC EDGAR